NASDAQ:ALRN

Aileron Therapeutics, Inc Earning Date

USA |NASDAQ |USD

ALRN Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 10, 2021 Sep 2021 $-0.07 $-0.06 $-0.13
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 10, 2021 Sep 2021 $0.00 $0.00 $0.00

Aileron Therapeutics, Inc's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 2021.

ALRN Earnings Date & History Chart

ALRN Earnings & Revenue Forecast

ALRN Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-0.08 $-0.08 $-0.08
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-0.30 $-0.30 $-0.29
Dec 2022 3 $-0.33 $-0.38 $-0.28

ALRN Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.08 $-0.08 $-0.09
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.30 $-0.31 $-0.32
Dec 2022 0 / 0 $-0.33 $-0.34 $-0.36

ALRN Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 3 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $0.00 $0.00 $0.00
Dec 2022 3 $0.00 $0.00 $0.00

ALRN Earnings Date & Revenue History

ALRN Earnings History

|
Show More
Show More

ALRN Revenue History

|
Show More
Show More

Aileron Therapeutics, Inc Next Earnings Date & Report

ALRN Next Earnings Date & Report Preview: Sep 2021 (FQ)

ALRN's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 3 analysts, the average EPS estimation for Aileron Therapeutics, Inc's next quarterly earnings is $-0.07, with a low EPS estimation of $-0.07, and a high estimation of $-0.07.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.07, the last 2 month trend is $-0.07, and the 3 month trend is $-0.08.

Based on 3 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Aileron Therapeutics, Inc Previous Earnings Dates & Reports

ALRN Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Aileron Therapeutics, Inc's previous earnings date was Aug 11, 2021 for its fiscal quarter ended Jun 30, 2021.

ALRN's earnings per share (EPS) was $-0.06, beating the consensus analysts forecast of $-0.07 by 14.29%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -25.00%, and higher than the same period a year before (Jun 2020) by -57.14%.

Revenues were $0.00.

The company reported a net income of $-5.69M.

Free cash flow for the quarter was $-3.83M , compared to $-6.56M last quarter and $-5.08M a year before.

ALRN ended the quarter with $221.00K in total debt, a decrease of -63.23% compared to the previous quarter, and a decrease of -74.71% compared to the same quarter a year before.

ALRN Previous Earnings Date & Report Recap: Dec 2020 (FY)

Aileron Therapeutics, Inc's previous annual earnings date was Mar 24, 2021 for its fiscal year ended Dec 31, 2020.

ALRN's earnings per share (EPS) was $-0.63, missing the consensus analysts forecast of $-0.61 by 3.28% , and higher than the previous year's EPS (Dec 2019) by -51.16%.

Revenues were $0.00.

The company reported a net income of $-21.16M.

Aileron Therapeutics, Inc reported a free cash flow of $-20.48M for its fiscal year, compared to $-26.62M a year ago.

The company ended the fiscal year with $387.00K in total debt, a decrease of -92.31% compared to the previous year.